Nath Bio Genes India Ltd vs Procter Gamble Hygiene And Health Care Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 10, 2026

Key Highlights

The Latest Trading Price of Nath Bio-Genes (India) Ltd is ₹ 137.75 as of 09 Oct 15:30 . The P/E Ratio of Nath Bio-Genes (India) Ltd changed from 7.7 on March 2023 to 5.8 on March 2026 . This represents a CAGR of -6.84% over 4 yearsThe P/E Ratio of Procter & Gamble Hygiene and Health Care Ltd changed from 0 on March 2022 to 0 on March 2026 . This represents a CAGR of 0.0% over 5 years The Market Cap of Nath Bio-Genes (India) Ltd changed from ₹ 405.45 crore on March 2022 to ₹ 242.59 crore on March 2026 . This represents a CAGR of -9.76% over 5 yearsThe Market Cap of Procter & Gamble Hygiene and Health Care Ltd changed from ₹ 0 crore on March 2022 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 5 years The revenue of Nath Bio-Genes (India) Ltd for the Jun '26 is ₹ 331.5 crore as compare to the Mar '26 revenue of ₹ 55.23 crore. This represent the growth of 500.22% The revenue of Procter & Gamble Hygiene and Health Care Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Nath Bio-Genes (India) Ltd for the Jun '26 is ₹ 38.25 crore as compare to the Mar '26 ebitda of ₹ 8.11 crore. This represent the growth of 371.64% The ebitda of Procter & Gamble Hygiene and Health Care Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Nath Bio-Genes (India) Ltd changed from ₹ 33.35 crore to ₹ 32.26 crore over 9 quarters. This represents a CAGR of -1.47% The net profit of Procter & Gamble Hygiene and Health Care Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The dividend payout of Nath Bio-Genes (India) Ltd changed from 9.02 % to 9.46 % over 6 quarters. This represents a CAGR of 3.23% The dividend payout of Procter & Gamble Hygiene and Health Care Ltd changed from 156.87 % to 0 % over 10 quarters. This represents a CAGR of -100.00% .

About Nath Bio-Genes (India) Ltd

Nath Bio-Genes (India) Limited was originally incorporated in the name and style of 'Shivnath Farms Private Limited' as Private Limited Company which thereafter was converted into Public Limited Company on 13 September, 2000 under the name and style of Shivnath Farms Limited' and further changed from Shivnath Farms Limited to Nath Bio-Genes (India) Limited on March 05, 2001. The Company stands as a distinguished leader in the Indian seed industry, leveraging over two decades of expertise in producing and distributing high-quality seeds to Indian farmers.
The Company's robust research and development initiatives have yielded numerous acclaimed cotton seed varieties, noted for their resilience against viruses and weather fluctuations, as evidenced by their outstanding performance in ICAR trials.

About Procter & Gamble Hygiene and Health Care Ltd

Procter & Gamble Hygiene and Health Care Limited (P&GHHCL) is engaged in manufacturing and selling of branded packaged fast moving consumer goods in the femcare and healthcare businesses.
The Company's products are sold through retail operations including mass merchandisers, grocery stores, membership club stores, drug stores, department stores and high frequency stores.
The Company has its manufacturing locations at Goa and Baddi in Himachal Pradesh, apart from third party manufacturing locations spread across India.. Procter & Gamble Hygiene and Health Care Limited was initially incorporated on 20th July 1964 at Mumbai as 'Procter & Gamble India Limited'.
The name of the Company was changed from 'Procter & Gamble India Limited' to 'Procter & Gamble Hygiene and Health Care Limited' in June, 1999.

FAQs for the comparison of Nath Bio-Genes (India) Ltd and Procter & Gamble Hygiene and Health Care Ltd

Which company has a larger market capitalization, Nath Bio-Genes (India) Ltd or Procter & Gamble Hygiene and Health Care Ltd?

Market cap of Nath Bio-Genes (India) Ltd is 261 Cr while Market cap of Procter & Gamble Hygiene and Health Care Ltd is 22,541 Cr

What are the key factors driving the stock performance of Nath Bio-Genes (India) Ltd and Procter & Gamble Hygiene and Health Care Ltd?

The stock performance of Nath Bio-Genes (India) Ltd and Procter & Gamble Hygiene and Health Care Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Nath Bio-Genes (India) Ltd and Procter & Gamble Hygiene and Health Care Ltd?

As of October 10, 2026, the Nath Bio-Genes (India) Ltd stock price is INR ₹137.75. On the other hand, Procter & Gamble Hygiene and Health Care Ltd stock price is INR ₹6944.2.

How do dividend payouts of Nath Bio-Genes (India) Ltd and Procter & Gamble Hygiene and Health Care Ltd compare?

To compare the dividend payouts of Nath Bio-Genes (India) Ltd and Procter & Gamble Hygiene and Health Care Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.